Prostate Cancer News

New Research Uncovers Promising New Biomarker for Aggressiveness of Prostate Cancer
Tuesday, October 23, 2012

BUFFALO — Research out of Roswell Park Cancer Institute (RPCI) supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors.

Media Advisory: Roswell Park, Buffalo Bills Team up on 'Know Your Stats' Awareness Campaign for Second Year
Thursday, October 4, 2012

WHAT:           One in six men will be diagnosed with prostate cancer, but with early detection, about 90 percent of these cancers will be cured....

Analyzing the PIVOT Study: Who are the Best Candidates for Prostatectomy vs. Observation?
Thursday, July 19, 2012

James L. Mohler, MD
Associate Director and Senior Vice President for Translational Research, Chair of the Department of Urology,...

PSA and the PSA Test: A Statement from Roswell Park Cancer Institute
Friday, October 7, 2011

As the pioneer of the PSA test, Roswell Park Cancer Institute (RPCI) has been in the frontlines of the...

James Mohler Appears Before Senate Committee On Foreign Relations
Wednesday, September 29, 2010

Roswell Park’s Dr. James Mohler Testified Today on Early Release of Convicted Pan Am Flight 103 Bomber.

Advocates Unite in Fight Against Prostate Cancer, "Man Up" Organization Formally Launched to Spread Awareness
Wednesday, June 16, 2010

BUFFALO, NY — African-American men are one-and-a-half times as likely as Caucasian men to be diagnosed with prostate cancer and, when diagnosed with prostate cancer, are more than twice as likely to die from...

RPCI Creates New Resource for Surgical Teams: First-Ever Virtual Manual on Robot-Assisted Surgery
Thursday, May 27, 2010

BUFFALO, NY — A Buffalo-based international expert on robot-assisted surgical techniques has created the first-ever virtual instructional manual on robot-assisted surgery. The interactive guide, “...

New Agent Puts the Brakes on Prostate Cancer in Men with Advanced Disease
Wednesday, May 26, 2010

Buffalo, NY — Men with metastatic prostate cancer who received the new biologic agent tasquinimod (TASQ) saw their progression-free survival time double compared to men who received a placebo, according to...

RPCI Researcher Receives Prostate Cancer Foundation Creativity Award for Dietary-Intervention Study
Thursday, May 13, 2010

Buffalo, NY — Dr. James Marshall, PhD, Senior Vice President for Cancer Prevention and Population Sciences at Roswell Park Cancer Institute (RPCI) and newly named Roswell Park Alliance Foundation Endowed...

Dr. Hannelore Heemers Receives Young Investigator Award From Prostate Cancer Foundation; Award to Accelerate New Discoveries for Battling Prostate Cancer
Tuesday, April 13, 2010

BUFFALO – Hannelore Heemers, PhD, a researcher in the Department of Urology at Roswell Park Cancer Institute, is the recipient of one of 21 Young Investigator Awards given by the Prostate Cancer Foundation (...